Macular disease and cataracts: Threshold for surgery should be low

Macular disease and cataracts: Threshold for surgery should be low
Dermot McGrath
Dermot McGrath
Published: Monday, September 26, 2016
congress-news_wolf_2096 Cataract surgery in patients with macular disease should be performed if the patient has cataract-related visual symptoms, according to Sebastian Wolf MD, PhD. “The take-home message is that the threshold for cataract surgery should be low and even patients with reduced visual potential may benefit from cataract surgery,” Dr Wolf told delegates attending yesterday’s ESCRS Clinical Research Symposium on cataract and macular disease in Copenhagen. Dr Wolf, of Switzerland, said that the question of whether cataract surgery is safe for someone with age-related macular degeneration (AMD) or other retinal disease is regularly posed by both patients and their treating physicians. While patients often worry that having the surgery will worsen their disease, there is no clear evidence that cataract surgery promotes AMD progression, he said. Dr Wolf said that cataract surgery is indicated when vision loss interferes with everyday activities. “We need to remember that cataract removal is one of the most common, safest and effective operations in medicine. In more than 90% of cases, people who have cataract surgery have better vision afterwards. Cataract surgery does, however, increase the risk of retinal detachment and it is true that the interaction between macular disease and cataract surgery is still very much under discussion,” he said. In terms of diagnostics that best predict the risk-benefit curve in patients with cataract and macular disease, Dr Wolf warned that ophthalmoscopy may be compromised by the presence of cataract. By contrast, optical coherence tomography (OCT) is also particularly useful in such patients, he said. “We typically use OCT, and the big advantage of this is that infrared light can penetrate even dense nuclear cataracts and give us a clearer view of the retina and macula,” he added.    
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...